作者：
Dinney,C.P.N. [1]
;
Fisher,M.B. [2]
;
Navai,N. [3]
;
O'Donnell,M.A. [4]
;
Cutler,D. [5]
;
Abraham,A. ;
Young,S. ;
Hutchins,B. ;
Caceres,M. ;
Kishnani,N. ;
Sode,G. ;
Cullen,C. ;
Zhang,G. ;
Grossman,H.B. ;
Kamat,A.M. ;
Gonzales,M. ;
Kincaid,M. ;
Ainslie,N. ;
Maneval,D.C. ;
Wszolek,M.F. ;
Benedict,W.F.
作者单位：
Department of Urology, University of Iowa, Iowa City, TX, United States
[1]
Merck, Sharp and Dohme Corp., Upper Gwynedd, PA, United States, Union and Kenilworth, NJ, United
[2]
Halozyme Therapeutics Inc., San Diego, CA, United States
[3]
Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center
[4]
Department of Urology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston
[5]
发布时间
2013-12-19
换一批
